Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL17508566 | 0.83 | THRB (0.59) | THRBMEN1KMT2ACA12CA7 | |
| Sulfuric Acid SCHEMBL4657293 | 0.83 | THRB (0.59) | THRBMEN1KMT2ACA12CA7 | |
| Sulfuric Acid SCHEMBL7095702 | 0.81 | THRB (0.56) | THRBMEN1KMT2ACA12CA7 | |
| Sulfuric Acid SCHEMBL9518722 | 0.81 | THRB (0.56) | THRBMEN1KMT2ACA12CA7 | |
| Sulfuric Acid SCHEMBL7095701 | 0.81 | THRB (0.56) | THRBMEN1KMT2ACA12CA7 | |
| Sulfuric Acid SCHEMBL28630346 | 0.81 | THRB (0.56) | THRBMEN1KMT2ACA12CA7 | |
| Sulfuric Acid SCHEMBL7095704 | 0.81 | THRB (0.56) | THRBMEN1KMT2ACA12CA7 | |
| SCHEMBL30432108 | 0.79 | THRB (0.53) | THRBMEN1KMT2ACA12CA7 | |
| Sulfuric Acid SCHEMBL15711221 | 0.76 | THRB (0.47) | THRBMEN1KMT2ACA12CA7 | |
| Sulfuric Acid SCHEMBL3390334 | 0.75 | THRB (0.62) | THRBMEN1KMT2ACA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7608730-B2 | Process for the preparation of an anti-tumor platinum (II)—complex | FRESENIUS KABI ONCOLOGY LIMITED (IN) | 2009-10-27 | — | — | US | disclosed |